Publications by authors named "M Pujol Sabate"

Unlabelled: Introduction y objectives: Tako-tsubo syndrome (TTS) is a cardiac condition that mimics acute coronary syndrome, characterized by transient left ventricular dysfunction in the absence of culprit coronary artery stenosis. Although its etiology remains unknown, reversible microvascular dysfunction secondary to an adrenergic surge is thought to play a role. Treatment is empirical, although most patients receive beta-blockers (BB) in clinical practice.

View Article and Find Full Text PDF
Article Synopsis
  • In patients with acute coronary syndromes and multivessel disease, immediate and staged complete revascularization showed similar outcomes at 2 years regarding combined health events like mortality and heart attacks.
  • A total of 1,525 patients participated, and follow-up data were collected from 97.6% of them.
  • The only notable difference was a lower rate of myocardial infarction in the immediate complete revascularization group compared to the staged group, suggesting it might be a slightly better option in preventing heart attacks.
View Article and Find Full Text PDF
Article Synopsis
  • * The study included 51 patients and found a high safety rate, with 92.2% free from target lesion failure at 180 days and 90.2% at one year.
  • * The new DCB showed significantly better results in reducing in-stent late lumen loss compared to standard balloon angioplasty, indicating its superior efficacy for ISR treatment.
View Article and Find Full Text PDF

3DStent is a novel rotational angiography imaging capable of 3D reconstruction and measuring stent area and diameter, without need for intravascular imaging. To compare 3DStent and OCT-derived stent area and diameter after PCI. Patients with de novo coronary lesions who underwent treatment with a single DES and evaluated by OCT and 3DStent were included.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined the 10-year outcomes of patients who underwent percutaneous coronary intervention (PCI) with drug-eluting stents (DES), focusing on different clinical presentations: acute coronary syndrome (ACS) and chronic coronary syndrome (CCS).
  • Data from five clinical trials involving 9,700 patients were analyzed, revealing that ACS patients had higher risks of all-cause death and non-target vessel revascularization within the first year, but risks equalized afterward.
  • ACS patients also faced increased risks of myocardial infarction and definite stent thrombosis compared to CCS patients, highlighting the need for further research on these outcomes with current treatment strategies.
View Article and Find Full Text PDF